Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Borgquist

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The British Journal of Surgery|September 7, 2016
Thyroid function and survival following breast cancerJ Brandt, S Borgquist, M Almquist, et al.
Journal of Internal Medicine|June 21, 2018
Statins: a role in breast cancer therapy?S Borgquist, O Bjarnadottir, S Kimbung, et al.
Breast (Edinburgh, Scotland)|June 22, 2016
Serum vitamin D (25OHD3) levels and the risk of different subtypes of breast cancer: A nested case-control studyL Shirazi, M Almquist, S Borgquist, et al.
Radiation Protection Dosimetry|September 28, 2015
ESTIMATES OF BREAST CANCER GROWTH RATE FROM MAMMOGRAMS AND ITS RELATION TO TUMOUR CHARACTERISTICSD Förnvik, K Lång, I Andersson, et al.
Journal of Clinical Pathology|January 29, 2008
Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancerS Borgquist, C Holm, M Stendahl, et al.
The British Journal of Surgery|November 10, 2011
Tumour-related factors and prognosis in breast cancer detected by screeningA Olsson, S Borgquist, S Butt, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 21, 2008
Parity in relation to survival following breast cancerS Butt, S Borgquist, J P Garne, et al.
Scientific Reports|June 24, 2024
Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groupsJ B Holm, E Baggesen, D Cronin-Fenton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 20, 2021
CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trialW He, M Eriksson, E Eliasson, et al.
Allergy|July 6, 2011
Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohortB Schlehofer, B Siegmund, J Linseisen, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The British Journal of Surgery|September 7, 2016
Thyroid function and survival following breast cancerJ Brandt, S Borgquist, M Almquist, et al.
Journal of Internal Medicine|June 21, 2018
Statins: a role in breast cancer therapy?S Borgquist, O Bjarnadottir, S Kimbung, et al.
Breast (Edinburgh, Scotland)|June 22, 2016
Serum vitamin D (25OHD3) levels and the risk of different subtypes of breast cancer: A nested case-control studyL Shirazi, M Almquist, S Borgquist, et al.
Radiation Protection Dosimetry|September 28, 2015
ESTIMATES OF BREAST CANCER GROWTH RATE FROM MAMMOGRAMS AND ITS RELATION TO TUMOUR CHARACTERISTICSD Förnvik, K Lång, I Andersson, et al.
Journal of Clinical Pathology|January 29, 2008
Oestrogen receptors alpha and beta show different associations to clinicopathological parameters and their co-expression might predict a better response to endocrine treatment in breast cancerS Borgquist, C Holm, M Stendahl, et al.
The British Journal of Surgery|November 10, 2011
Tumour-related factors and prognosis in breast cancer detected by screeningA Olsson, S Borgquist, S Butt, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 21, 2008
Parity in relation to survival following breast cancerS Butt, S Borgquist, J P Garne, et al.
Scientific Reports|June 24, 2024
Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groupsJ B Holm, E Baggesen, D Cronin-Fenton, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 20, 2021
CYP2D6 genotype predicts tamoxifen discontinuation and drug response: a secondary analysis of the KARISMA trialW He, M Eriksson, E Eliasson, et al.
Allergy|July 6, 2011
Primary brain tumours and specific serum immunoglobulin E: a case-control study nested in the European Prospective Investigation into Cancer and Nutrition cohortB Schlehofer, B Siegmund, J Linseisen, et al.
Pageof 2